United Therapeutics | UTHR - Market Capitalization


United Therapeutics reported $25.88B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amarin USD 290M 51M Dec/2025
Baxter International USD 8.67B 1.15B Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 885M 351M Dec/2025
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Insmed USD 35.3B 1.82B Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Moderna USD 20.15B 8.53B Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
PTC Therapeutics USD 5.64B 460M Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026